July 06, 2024
1 min watch
Save
VIDEO: ‘More movement’ in nontransplant-eligible multiple myeloma population
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
CHICAGO — In this video, Sandra Mazzoni, DO, highlights data in nontransplant-eligible patients with multiple myeloma presented at ASCO Annual Meeting.
“There are a lot of studies in the nontransplant-eligible population presented, and I think that that space has not had a lot of movement,” Mazzoni, hematologist with the Cleveland Clinic, said. “I’m glad to see it’s starting to have more movement and bringing a lot of these new therapies up front.”
Reference:
- Manier S, et al. Abstract 7506. Presented at: ASCO Annual Meeting; May 31-June 4, 2024; Chicago.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Mazzoni reports consulting for Janssen.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.